C
Cengild Medical Bhd
KLSE:CENGILD
Cengild Medical Bhd
KLSE:CENGILD
Price:
0.225
MYR
-2.17%
Market Cap:
187.4m
MYR
Income Statement
Earnings Waterfall
Cengild Medical Bhd
Cengild Medical Bhd
Income Statement
Cengild Medical Bhd
Cengild Medical Bhd
Currency: MYR
| Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||
| Interest Expense |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
64
N/A
|
67
+5%
|
70
+4%
|
72
+3%
|
70
-2%
|
70
0%
|
67
-5%
|
66
-1%
|
67
+1%
|
72
+7%
|
76
+6%
|
77
+2%
|
80
+4%
|
76
-5%
|
75
-2%
|
|
| Gross Profit | ||||||||||||||||
| Cost of Revenue |
(38)
|
(40)
|
(40)
|
(41)
|
(40)
|
(39)
|
(37)
|
(36)
|
(36)
|
(38)
|
(41)
|
(42)
|
(43)
|
(41)
|
(40)
|
|
| Gross Profit |
26
N/A
|
28
+7%
|
29
+6%
|
31
+5%
|
31
0%
|
31
+1%
|
30
-3%
|
31
+1%
|
31
+1%
|
33
+7%
|
35
+5%
|
35
+1%
|
37
+4%
|
35
-5%
|
35
-1%
|
|
| Operating Income | ||||||||||||||||
| Operating Expenses |
(13)
|
(12)
|
(12)
|
(12)
|
(13)
|
(13)
|
(14)
|
(14)
|
(13)
|
(16)
|
(18)
|
(20)
|
(18)
|
(19)
|
(20)
|
|
| Selling, General & Administrative |
(14)
|
(14)
|
(14)
|
(15)
|
(16)
|
(17)
|
(18)
|
(18)
|
(18)
|
(20)
|
(22)
|
(24)
|
(22)
|
(22)
|
(22)
|
|
| Other Operating Expenses |
1
|
2
|
3
|
3
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
3
|
3
|
|
| Operating Income |
13
N/A
|
15
+19%
|
18
+13%
|
19
+7%
|
18
-4%
|
18
-1%
|
17
-8%
|
17
+2%
|
18
+5%
|
18
0%
|
17
-1%
|
16
-10%
|
18
+17%
|
16
-14%
|
15
-4%
|
|
| Pre-Tax Income | ||||||||||||||||
| Interest Income Expense |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
1
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
|
| Total Other Income |
(0)
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Pre-Tax Income |
12
N/A
|
15
+22%
|
17
+14%
|
18
+8%
|
17
-4%
|
17
-1%
|
16
-8%
|
16
+0%
|
17
+6%
|
17
+0%
|
17
+0%
|
16
-7%
|
18
+15%
|
16
-10%
|
16
-3%
|
|
| Net Income | ||||||||||||||||
| Tax Provision |
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(5)
|
(5)
|
(5)
|
(5)
|
(4)
|
(4)
|
(3)
|
|
| Income from Continuing Operations |
9
|
12
|
13
|
15
|
13
|
13
|
12
|
12
|
12
|
11
|
11
|
10
|
14
|
12
|
12
|
|
| Net Income (Common) |
9
N/A
|
12
+24%
|
13
+15%
|
15
+11%
|
13
-11%
|
13
0%
|
12
-9%
|
12
-2%
|
11
-6%
|
11
+4%
|
11
+0%
|
10
-10%
|
11
+7%
|
10
-10%
|
10
-3%
|
|
| EPS (Diluted) |
0.01
N/A
|
0.03
+200%
|
0.01
-67%
|
0.01
N/A
|
0.02
+100%
|
0.01
-50%
|
0
N/A
|
0.01
N/A
|
0.01
N/A
|
0.01
N/A
|
0.01
N/A
|
0.01
N/A
|
0.02
+100%
|
0.02
N/A
|
0.01
-50%
|
|
Switch to:
Switch to:
See Also
Discover More
